Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
07.11.20 50%
sell
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
05.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.92
31.10.20
-
04.11.21
20.56%
09.11.20

DrMabuse 
31.10.20 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€16.60
31.10.20
-
04.11.21
24.82%
09.11.20

DrMabuse 
31.10.20 50%
sell
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
yester 
21.09.20 50%
sell
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
07.09.20
-
04.11.21
-21.91%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
07.09.20 50%
sell
Ceapro Inc

Start price
Target price
Perf. (%)
€0.41
03.09.20
-
03.09.20
-
03.09.20

DrMabuse 
03.09.20 50%
buy
Ceapro Inc

Start price
Target price
Perf. (%)
€0.59
22.08.20
-
03.09.20
-9.40%
03.09.20

DrMabuse 
22.08.20 50%
buy
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.76
22.08.20
-
07.09.20
-5.48%
07.09.20

Could be very worthwhile Investment >20% year
Biotechhunter 
22.08.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.27
14.07.20
€5.85
05.08.20
-5.09%
05.08.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
14.07.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.70
24.05.20
€5.00
26.06.20
-0.54%
26.06.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
24.05.20 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.08
20.05.20
€4.50
04.11.21
56.99%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
20.05.20 50%
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.01
28.04.20
€1.00
04.11.21
35.05%
05.11.21

Could be very worthwhile Investment >20% year
woelli 
28.04.20 60%
buy
THC Biomed International Inc.

Start price
Target price
Perf. (%)
€0.070
17.04.20
-
04.11.21
-21.43%
14.10.21

Mori8 
17.04.20 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€13.53
30.03.20
€29.00
04.11.21
72.28%
05.11.21

stratec 
30.03.20 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€7.15
26.03.20
-
04.11.21
10.29%
05.11.21

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
26.03.20 0%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€5.44
13.03.20
€9.32
24.07.20
-15.48%
24.07.20

Subdi 
13.03.20 50%
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€2.80
04.01.20
-
04.11.21
112.50%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
04.01.20 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€18.00
21.12.19
€30.00
04.11.21
-36.06%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Maxi_Scalibusa 
21.12.19 60%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.29
25.11.19
-
04.11.21
196.12%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Maxi_Scalibusa 
25.11.19 0%
buy
Vbi Vaccines Inc

Start price
Target price
Perf. (%)
-
14.11.19
€1.00
24.11.19
-
24.11.19

DomRuinart 
14.11.19 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€1.73
03.06.19
€2.35
20.06.19
36.98%
20.06.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Acasti Pharma Inc.

Start price
Target price
Perf. (%)
€38.96
01.06.19
€49.79
25.06.19
28.90%
25.06.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Novelion Therapeutics Inc.

Start price
Target price
Perf. (%)
?0.83
27.05.19
€1.17
15.11.19
0.00%
15.11.19

melinda 
18.08.19 50%
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€1.81
26.05.19
€2.71
05.07.19
49.91%
05.07.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%